A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

Clinical trial NCT05813678 · RECRUITING

Trial details

NCT number: NCT05813678
Sponsor: BioMarin Pharmaceutical
Status: RECRUITING
Study type: OBSERVATIONAL

Phenylketonuria (PKU)

Start date: 2022-06-06
Primary completion: 2033-11-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.